Label: GERICARE SORBITOL SOLUTION- sorbitol liquid
- NDC Code(s): 57896-758-16
- Packager: GERI-CARE PHARMACEUTICALS, CORP
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
Drug Label Information
Updated December 31, 2025
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- ACTIVE INGREDIENT
- PURPOSE
- INDICATIONS & USAGE
-
WARNINGS
Warnings
For rectal use only
Do not use
- when abdominal pain, nausea, or vomiting are present
- for more than one week unless directed by a doctor
Ask a doctor before use if
- are taking mineral oil
- have noticed a sudden change in bowel habits that lasts over 2 weeks
Stop use and aska doctor if you have a rectal bleeding or no bowel movement after using this product. These could be signs of a serious condition.
- PREGNANCY OR BREAST FEEDING
- KEEP OUT OF REACH OF CHILDREN
-
DOSAGE & ADMINISTRATION
Directions Do not exceed recommended dose
AGE DOSE Adults and children 12 years and over For rectal use only. Enema dosage is 120 mL of a 25 to 30% w/v solution (1 part of this product with 2.3 parts water) in a single daily dose as needed, or as directed by your doctor. Children under 12 years of age Ask a doctor - INACTIVE INGREDIENT
- QUESTIONS
- PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
GERICARE SORBITOL SOLUTION
sorbitol liquidProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:57896-758 Route of Administration RECTAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength SORBITOL (UNII: 506T60A25R) (SORBITOL - UNII:506T60A25R) SORBITOL 70 mg in 100 mL Inactive Ingredients Ingredient Name Strength WATER (UNII: 059QF0KO0R) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:57896-758-16 473 mL in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug M007 01/01/2020 Labeler - GERI-CARE PHARMACEUTICALS, CORP (611196254)

